Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.

BACKGROUND CONTEXT The commercially available growth factor recombinant bone morphogenic protein-2 (rhBMP-2) used in spinal fusion has been associated with numerous adverse reactions, including inflammatory reactions in soft tissue, heterotopic bone formation, radiculitis, osteolysis, and cage or graft subsidence. The original Food and Drug Administration Summary of anterior lumbar interbody fusion (ALIF) reported 12 retrograde ejaculation (RE) events (8%) in the rhBMP-2 groups compared with (1.4%) in the control group. It had been debated whether this finding was related to rhBMP-2 use. PURPOSE To compare the incidence of RE after ALIF in patients with and without rhBMP-2 use. STUDY DESIGN Retrospective analysis of prospectively gathered outcomes data on consecutive subjects having ALIF with and without rhBMP-2 use. PATIENT SAMPLE Male patients with lumbar spondylosis or spondylolisthesis having ALIF of the lowest one or two lumbar levels with and without rhBMP-2. OUTCOME MEASURE Report of RE as a new finding after ALIF. METHODS From the comprehensive outcome database at a high-volume university practice, male subjects having ALIF for one- (L5/S1) or two-level (L4/L5, L5/S1) lumbar fusion were identified. Retrograde ejaculation events were recorded and comparative incidence compared. RESULTS The two groups were comparable for age and additional procedures performed. There were 69 L5/S1 ALIFs performed with rhBMP-2 and 174 ALIFs performed without rhBMP-2 during the study period. Of those, 24 and 64 were two-level ALIFs performed with and without rhBMP-2, respectively. There were five RE events (7.2%) reported in the rhBMP-2 group and 1 (0.6%) in the control group. Comparing single-level L5/S1 ALIF, there was a 6.7% and 0% rate of RE in the rhBMP-2 versus control groups, respectively. At 1 year after surgery, three of six affected subjects reported resolution of the RE. CONCLUSION This study confirms previous reports of a higher rate of RE in ALIF procedures using rhBMP-2. This may be an important consideration in subjects concerned with sterility after surgery.

[1]  Marija Rakovac,et al.  Could chronic host inflammatory response be responsible for delayed onset of retrograde ejaculation after the labeled use of recombinant human bone morphogenetic protein-2? , 2011, The spine journal : official journal of the North American Spine Society.

[2]  C. Knox,et al.  Osteolysis in Transforaminal Lumbar Interbody Fusion with Bone Morphogenetic Protein-2 , 2011, Spine.

[3]  R. Sasso,et al.  Retrograde Ejaculation After Anterior Lumbar Interbody Fusion: Transperitoneal Versus Retroperitoneal Exposure , 2003, Spine.

[4]  R. Deyo,et al.  Variation in Reported Safety of Lumbar Interbody Fusion: Influence of Industrial Sponsorship and Other Study Characteristics , 2007, Spine.

[5]  E. Carragee,et al.  Clinical Outcomes After Lumbar Discectomy for Sciatica: The Effects of Fragment Type and Anular Competence , 2003, The Journal of bone and joint surgery. American volume.

[6]  B. Subach,et al.  Comparison of the Mini-open versus Laparoscopic Approach for Anterior Lumbar Interbody Fusion: A Retrospective Review , 2002, Neurosurgery.

[7]  E. Carragee,et al.  A Prospective Analysis of Magnetic Resonance Imaging Findings in Patients With Sciatica and Lumbar Disc Herniation: Correlation of Outcomes With Disc Fragment and Canal Morphology , 1997, Spine.

[8]  P. Klimo,et al.  Use of polyetheretherketone spacer and recombinant human bone morphogenetic protein-2 in the cervical spine: a radiographic analysis. , 2009, The spine journal : official journal of the North American Spine Society.

[9]  Joseph D. Smucker,et al.  Increased Swelling Complications Associated With Off-Label Usage of rhBMP-2 in the Anterior Cervical Spine , 2006, Spine.

[10]  Marija Rakovac,et al.  Re: Sasso RC, Burkus JK, LeHuec JC. Retrograde ejaculation after anterior lumbar interbody fusion: transperitoneal versus retroperitoneal exposure. Spine (Phila Pa 1976) 2003;28:1023-6. , 2010, Spine.

[11]  T. Zdeblick,et al.  Is INFUSE Bone Graft Superior to Autograft Bone? An Integrated Analysis of Clinical Trials Using the LT-CAGE Lumbar Tapered Fusion Device , 2003, Journal of spinal disorders & techniques.

[12]  R. Vaidya,et al.  Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence. , 2007, The Journal of bone and joint surgery. British volume.

[13]  G. Rodts,et al.  Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion. , 2007, The spine journal : official journal of the North American Spine Society.

[14]  N. Anand,et al.  Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. , 2007, The spine journal : official journal of the North American Spine Society.

[15]  Kai-Ming G. Fu,et al.  Complications Associated with BMP Use in 11,933 Cases of Spinal Fusion , 2010 .

[16]  T. Albert,et al.  Complications associated with single-level transforaminal lumbar interbody fusion. , 2009, The spine journal : official journal of the North American Spine Society.

[17]  Sheng-hua Lu,et al.  Clinical anatomy study of autonomic nerve with respective to the anterior approach lumbar surgery , 2009, Surgical and Radiologic Anatomy.

[18]  M. Helgeson,et al.  Adjacent vertebral body osteolysis with bone morphogenetic protein use in transforaminal lumbar interbody fusion. , 2008, The spine journal : official journal of the North American Spine Society.

[19]  E. Carragee,et al.  Pseudomorbidity in iliac crest bone graft harvesting: the rise of rhBMP-2 in short-segment posterior lumbar fusion. , 2009, The spine journal : official journal of the North American Spine Society.

[20]  D. Norvell,et al.  Complications Related to Osteobiologics Use in Spine Surgery: A Systematic Review , 2010, Spine.

[21]  E. Hurwitz,et al.  Surgical treatment for unstable low-grade isthmic spondylolisthesis in adults: a prospective controlled study of posterior instrumented fusion compared with combined anterior-posterior fusion. , 2006, The spine journal : official journal of the North American Spine Society.

[22]  E. Carragee,et al.  17. A Controlled Trial of BMP and Unilateral Transpedicular Instrumentation in Circumferential Single or Double Level Lumbar Fusion , 2007 .

[23]  T. Smoljanović,et al.  Re: Mroz TE, Wang JC, Hashimoto R, et al.Complications related to osteobiologics use in spine surgery: a systematic review. Spine (Phila Pa 1976) 2010;35:S86-104. , 2010, Spine.

[24]  J. Heller,et al.  Anterior Exposure of the Lumbar Spine With and Without an “Access Surgeon”: Morbidity Analysis of 265 Consecutive Cases , 2009, Journal of spinal disorders & techniques.

[25]  M. Pećina,et al.  Re: Burkus J K, Sandhu H S, Gornet M F. Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft. Spine 2006;31:775-81. , 2008, Spine.

[26]  S. Jatana,et al.  Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). , 2008, The spine journal : official journal of the North American Spine Society.

[27]  J. Burkus,et al.  Influence of rhBMP-2 on the Healing Patterns Associated With Allograft Interbody Constructs in Comparison With Autograft , 2006, Spine.

[28]  Sang-Ho Lee,et al.  An analysis of general surgery-related complications in a series of 412 minilaparotomic anterior lumbosacral procedures. , 2009, Journal of neurosurgery. Spine.

[29]  T. Smoljanović,et al.  Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2. , 2010, The Journal of bone and joint surgery. American volume.

[30]  A. Nowitzke,et al.  Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost? , 2011, The spine journal : official journal of the North American Spine Society.